CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy

Overview of attention for article published in Frontiers in Pharmacology, February 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 144,578 followers.

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy https://t.co/FhFvvffLv6 #pharmacology #openaccess

RT @_atanas_: CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy https://t.co/nNohOSdIdX

RT @_atanas_: CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy https://t.co/nNohOSdIdX

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy https://t.co/nNohOSdIdX

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.